Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Looking anew at cognitive dysfunction in multiple sclerosis: The gorilla in the room.
Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen.
Decoding Signaling and Function of the Orphan G Protein-Coupled Receptor GPR17 with a Small-Molecule Agonist.
Hatha Yoga and Executive Function: A Systematic Review.
Effect of Smoking Cessation on Multiple Sclerosis Prognosis.
Natalizumab-induced hepatic injury: A case report and review of literature.
Comparison of brain 3.0-T with 1.5-T MRI in patients with multiple sclerosis: A 6-month follow-up study.
The Persian Version of Community Integration Questionnaire in persons with multiple sclerosis: translation, reliability, validity, and factor analysis.
Punctate lesion pattern suggestive of perivascular inflammation in acute natalizumab-associated progressive multifocal leukoencephalopathy: productive JC virus infection or preclinical PML-IRIS manifestation?
Advancing therapeutic options in multiple sclerosis with neuroprotective properties.
Discovery of novel N-(5-(arylcarbonyl)thiazol-2-yl)amides and N-(5-(arylcarbonyl)thiophen-2-yl)amides as potent RORγt inhibitors.
159 Microsurgical descending tractotomy in cases of intractable trigeminal pain syndromes.
MRI correlates of disability in african-americans with multiple sclerosis.
R PheWAS: Data Analysis and Plotting Tools for Phenome Wide Association Studies in the R Environment.
An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex.
Navigating the "liberation procedure": a qualitative study of motivating and hesitating factors among people with multiple sclerosis.
Confounding Psychosis in the Postpartum Period.
Care of patients with multiple sclerosis.
Methods for the detection of peptidylarginine deiminase activity and protein citrullination.
FTY720 (fingolimod) is a neuroprotective and disease-modifying agent in cellular and mouse models of Huntington disease.
[Quality of life of patients receiving long-term treatment with first-line disease-modifying drugs: results of a Russian multicenter study using MusiQoL.]
Multiple Sclerosis Alters the Mechanical Work Performed on the Body's Center of Mass during Gait.
Comparison of patient-reported outcome measures in multiple sclerosis.
Mobility and cognitive correlates of dual task cost of walking in persons with multiple sclerosis.
Fornix as an imaging marker for episodic memory deficits in healthy aging and in various neurological disorders.

Pages